BIOFILCHEM Stock Overview Manufactures and trades in pharmaceuticals in India. More details
Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Biofil Chemicals and Pharmaceuticals Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Biofil Chemicals and Pharmaceuticals Historical stock prices Current Share Price ₹59.24 52 Week High ₹91.87 52 Week Low ₹53.45 Beta 2.11 1 Month Change 0.068% 3 Month Change -29.06% 1 Year Change 6.93% 3 Year Change -1.10% 5 Year Change 186.88% Change since IPO 158.13%
Recent News & Updates
Biofil Chemicals and Pharmaceuticals Limited Announces Resignation Anisha Mangal as Company Secretary and Compliance Officer Dec 19
Biofil Chemicals and Pharmaceuticals Limited Announces Resignation of Romil Shah as Non Executive Non Independent Director Nov 27
Second quarter 2025 earnings released: EPS: ₹0.01 (vs ₹0.08 in 2Q 2024) Nov 18
Biofil Chemicals and Pharmaceuticals Limited to Report Q2, 2025 Results on Nov 14, 2024 Nov 08
New minor risk - Share price stability Sep 16
Biofil Chemicals and Pharmaceuticals Limited Announces Appointment of Ms. Anisha Mangal as Company Secretary (Kmp) Sep 14 See more updates
Biofil Chemicals and Pharmaceuticals Limited Announces Resignation Anisha Mangal as Company Secretary and Compliance Officer Dec 19
Biofil Chemicals and Pharmaceuticals Limited Announces Resignation of Romil Shah as Non Executive Non Independent Director Nov 27
Second quarter 2025 earnings released: EPS: ₹0.01 (vs ₹0.08 in 2Q 2024) Nov 18
Biofil Chemicals and Pharmaceuticals Limited to Report Q2, 2025 Results on Nov 14, 2024 Nov 08
New minor risk - Share price stability Sep 16
Biofil Chemicals and Pharmaceuticals Limited Announces Appointment of Ms. Anisha Mangal as Company Secretary (Kmp) Sep 14
First quarter 2025 earnings released: EPS: ₹0.10 (vs ₹0.15 in 1Q 2024) Aug 15
Biofil Chemicals and Pharmaceuticals Limited, Annual General Meeting, Sep 30, 2024 Aug 14
Biofil Chemicals and Pharmaceuticals Limited to Report Q1, 2025 Results on Aug 13, 2024 Aug 08
Biofil Chemicals and Pharmaceuticals Limited Announces Resignation of Shweta Verma as Company Secretary and Compliance Officer Jul 04
Full year 2024 earnings released: EPS: ₹0.44 (vs ₹0.34 in FY 2023) Jun 04
Biofil Chemicals and Pharmaceuticals Limited to Report Q4, 2024 Results on May 30, 2024 May 24
Biofil Chemicals and Pharmaceuticals Limited Announces Smt. Shaila Jain Will Retire from Independent Directorship as Well as from All the Committees of Board of Directors, Effective 31 March, 2024 Mar 30
Third quarter 2024 earnings released: EPS: ₹0.06 (vs ₹0.06 in 3Q 2023) Feb 09
Biofil Chemicals and Pharmaceuticals Limited to Report Q3, 2024 Results on Feb 06, 2024 Jan 31
New minor risk - Share price stability Jan 25
Second quarter 2024 earnings released: EPS: ₹0.08 (vs ₹0.03 in 2Q 2023) Nov 12
Biofil Chemicals and Pharmaceuticals Limited to Report Q2, 2024 Results on Nov 09, 2023 Nov 02
Biofil Chemicals and Pharmaceuticals Limited Announces Change in Designation of Gayatri Padiyar from Additional Director to Non-Executive Independent Director Sep 28
Biofil Chemicals and Pharmaceuticals Limited, Annual General Meeting, Sep 27, 2023 Aug 25
New major risk - Revenue and earnings growth Aug 17
First quarter 2024 earnings released: EPS: ₹0.15 (vs ₹0.13 in 1Q 2023) Aug 16
Biofil Chemicals and Pharmaceuticals Limited to Report Q1, 2024 Results on Aug 14, 2023 Aug 06
Full year 2023 earnings released: EPS: ₹0.29 (vs ₹0.43 in FY 2022) Jun 04
Biofil Chemicals and Pharmaceuticals Limited to Report Q4, 2023 Results on May 30, 2023 May 23
Third quarter 2023 earnings released: EPS: ₹0.06 (vs ₹0.21 in 3Q 2022) Feb 16
Biofil Chemicals and Pharmaceuticals Limited to Report Q3, 2023 Results on Feb 14, 2023 Feb 08
Biofil Chemicals and Pharmaceuticals Limited Announces Changes in Company Secretary / Compliance Officer Dec 24
Biofil Chemicals and Pharmaceuticals Limited Announces Resignation of Shikha Khilwani as Company Secretary and Compliance Officer, Effective 23 December, 2022 Dec 17
Second quarter 2023 earnings released: EPS: ₹0.03 (vs ₹0.13 in 2Q 2022) Nov 20
Biofil Chemicals and Pharmaceuticals Limited Appoints Pawan Singh Rajput as Chief Financial Officer Nov 16
First quarter 2023 earnings released: EPS: ₹0.13 (vs ₹0.11 in 1Q 2022) Aug 11
Biofil Chemicals and Pharmaceuticals Limited Announces Resignation of Jitendra Kumar Sahu as CFO , Effective on June 30, 2022 Jun 23
Full year 2022 earnings released: EPS: ₹0.44 (vs ₹0.76 in FY 2021) Jun 04
Biofil Chemicals and Pharmaceuticals Limited to Report Q4, 2022 Results on May 30, 2022 May 22
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Feb 17
Full year 2021 earnings released: EPS ₹0.76 (vs ₹0.74 in FY 2020) Jul 03
Investor sentiment improved over the past week Apr 26
Investor sentiment deteriorated over the past week Mar 16
Investor sentiment improved over the past week Feb 27
Investor sentiment deteriorated over the past week Feb 12
Biofil Chemicals and Pharmaceuticals Limited to Report Q3, 2021 Results on Feb 12, 2021 Feb 06
New 90-day low: ₹97.80 Feb 01
Biofil Chemicals and Pharmaceuticals Limited's (NSE:BIOFILCHEM) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? Jan 01
New 90-day high: ₹116 Nov 07
Biofil Chemicals and Pharmaceuticals Limited to Report Q2, 2021 Results on Nov 11, 2020 Nov 05
New 90-day high: ₹59.90 Oct 06
Biofil Chemicals and Pharmaceuticals Limited's (NSE:BIOFILCHEM) Shares Climb 60% But Its Business Is Yet to Catch Up Sep 18
New 90-day high - ₹43.15 Sep 11
There's Reason For Concern Over Biofil Chemicals and Pharmaceuticals Limited's (NSE:BIOFILCHEM) Price Sep 03
First quarter earnings released Aug 27
Biofil Chemicals and Pharmaceuticals Limited to Report Q1, 2021 Results on Aug 25, 2020 Aug 21
New 90-day high - ₹28.40 Aug 14
Getting In Cheap On Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM) Is Unlikely Jul 18
New 90-day high - ₹16.20 Jul 16 Shareholder Returns BIOFILCHEM IN Pharmaceuticals IN Market 7D -7.1% 0.8% -4.3% 1Y 6.9% 39.7% 19.1%
See full shareholder returns
Return vs Market: BIOFILCHEM underperformed the Indian Market which returned 19.1% over the past year.
Price Volatility Is BIOFILCHEM's price volatile compared to industry and market? BIOFILCHEM volatility BIOFILCHEM Average Weekly Movement 6.1% Pharmaceuticals Industry Average Movement 6.0% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.0% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: BIOFILCHEM has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: BIOFILCHEM's weekly volatility (6%) has been stable over the past year.
About the Company Biofil Chemicals and Pharmaceuticals Limited manufactures and trades in pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic drippers and caps for packing applications.
Show more Biofil Chemicals and Pharmaceuticals Limited Fundamentals Summary How do Biofil Chemicals and Pharmaceuticals's earnings and revenue compare to its market cap? BIOFILCHEM fundamental statistics Market cap ₹967.80m Earnings (TTM ) ₹5.36m Revenue (TTM ) ₹314.53m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) BIOFILCHEM income statement (TTM ) Revenue ₹314.53m Cost of Revenue ₹289.55m Gross Profit ₹24.98m Other Expenses ₹19.62m Earnings ₹5.36m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 0.33 Gross Margin 7.94% Net Profit Margin 1.70% Debt/Equity Ratio 2.5%
How did BIOFILCHEM perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/22 05:07 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Biofil Chemicals and Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
